Supplemental material
OncoImmunology
Volume 6, 2017 - Issue 3
Original Research
IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo
Margherita BoieriDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;Department of Immunology, Oslo University Hospital, Oslo, Norway
http://orcid.org/0000-0002-9416-0536
http://orcid.org/0000-0002-9416-0536, , , Clare LendremInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle-upon-Tyne, UKhttp://orcid.org/0000-0002-9435-7398
http://orcid.org/0000-0002-9435-7398, , , Lise KvebergDepartment of Immunology, Institute of Clinical Medicine, University of Oslo, Oslo, Norwayhttp://orcid.org/0000-0001-9308-0641
http://orcid.org/0000-0001-9308-0641 & Marit InngjerdingenDepartment of Immunology, Oslo University Hospital, Oslo, NorwayCorrespondence[email protected]
http://orcid.org/0000-0001-8965-661X
http://orcid.org/0000-0001-8965-661X show all